4//SEC Filing
Broadfin Healthcare Master Fund Ltd 4
Accession 0001103021-21-000046
CIK 0001103021other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:38 PM ET
Size
13.6 KB
Accession
0001103021-21-000046
Insider Transaction Report
Form 4
KOTLER KEVIN
Director
Transactions
- Purchase
Common Stock
2021-05-11$3.16/sh+150,000$474,000→ 4,505,689 total(indirect: See footnote) - Purchase
Common Stock
2021-05-13$3.25/sh+50,000$162,500→ 4,655,689 total(indirect: See footnote) - Purchase
Common Stock
2021-05-12$3.24/sh+100,000$324,000→ 4,605,689 total(indirect: See footnote)
Broadfin Capital, LLC
Director
Transactions
- Purchase
Common Stock
2021-05-12$3.24/sh+100,000$324,000→ 4,605,689 total(indirect: See footnote) - Purchase
Common Stock
2021-05-11$3.16/sh+150,000$474,000→ 4,505,689 total(indirect: See footnote) - Purchase
Common Stock
2021-05-13$3.25/sh+50,000$162,500→ 4,655,689 total(indirect: See footnote)
Transactions
- Purchase
Common Stock
2021-05-12$3.24/sh+100,000$324,000→ 4,605,689 total(indirect: See footnote) - Purchase
Common Stock
2021-05-11$3.16/sh+150,000$474,000→ 4,505,689 total(indirect: See footnote) - Purchase
Common Stock
2021-05-13$3.25/sh+50,000$162,500→ 4,655,689 total(indirect: See footnote)
Footnotes (6)
- [F1]On May 11, 2021, the Reporting Person purchased an aggregate of 150,000 shares of the Issuer's Common Stock at a weighted average price of $3.16 per share. The highest purchase price for the Common Stock was $3.17 per share and the lowest purchase price was $3.07 per share.
- [F2]The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in these footnotes.
- [F3]300,000 shares of Common Stock are held in the account of Broadfin Holdings, LLC., a private investment fund, and are deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Holdings, LLC.
- [F4]4,355,689 shares of Common Stock are held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC, and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Broadfin Healthcare Master Fund, Ltd., Broadfin Capital, LLC, and Kevin Kotler affirmatively (i) disclaim beneficial ownership of the reportable securities, (ii) states that this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 ("Section 16") of the Securities Exchange Act of1934, as amended (the "Act") or any other purpose, except to the extent of their pecuniary interest therein, and (iii) disclaim being a "group" for purposes of Section 16.
- [F5]On May 12, 2021, the Reporting Person purchased an aggregate of 100,000 shares of the Issuer's Common Stock at a weighted average price of $3.24 per share. The highest purchase price for the Common Stock was $3.28 per share and the lowest purchase price was $3.13 per share.
- [F6]On May 13, 2021, the Reporting Person purchased an aggregate of 50,000 shares of the Issuer's Common Stock at a weighted average price of $3.25 per share. The highest purchase price for the Common Stock was $3.27 per share and the lowest purchase price was $3.24 per share.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001511900
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 5:38 PM ET
- Size
- 13.6 KB